FDA Drug Application (202139) for INDOMETHACIN by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number202139
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage75MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameINDOMETHACIN
Active IngredientINDOMETHACIN

Active IngredientCount
List of drugs with Active Ingredient INDOMETHACIN5


Back to FDA Applications sponsored by MYLAN PHARMS INC